Sean McClain
Founder, CEO, President & Director
Good morning, everybody. Thanks for becoming a member of our deep dive at present into ABS-201. At Absci, our mission is to make use of generative AI to create higher biologics for sufferers who haven’t got adequate choices at present. We discuss rather a lot about our platform, our lab-in-the-loop, and our means to create higher biologics sooner. However at present is not simply in regards to the platform within the summary, at present is in regards to the outcomes. ABS-201, which we consider could possibly be a paradigm-changing therapeutic for androgenic alopecia.
Now traditionally, the biopharma trade has dismissed hair loss as simply beauty. However while you converse to sufferers, you notice that characterization is deeply flawed. For tens of tens of millions of individuals, each women and men, this isn’t about self-importance. It is about identification. It is about psychological well being and the profound lack of confidence that impacts their every day lives.
Regardless of this large unmet medical want, the usual of care has remained stagnant for many years, we’re counting on outdated mechanisms that usually include troublesome trade-offs. Because of this we’re so enthusiastic about ABS-201, by leveraging our AI drug creation platform, now we have
